GDRX vs HIMS
GDRX: GoodRx is a leading digital healthcare platform that provides price transparency and discount tools to help Americans save money on prescription medications and access healthcare services. HIMS: A consumer-first digital health platform transforming the fulfillment of healthcare services and wellness products through an integrated telehealth and pharmacy model.
Side-by-side fundamentals
| Metric | GDRX | HIMS | Edge |
|---|---|---|---|
| Price as of 2026-08-11 close | $3.80 | $30.51 | |
| Market cap as of 2026-08-12 | $1.2B | $7.4B | |
| P/E as of 2026-08-12 | 76.84 | 57.29 | HIMS lower |
| PEG as of 2026-08-12 | -47.17 | n/a | |
| Net margin as of 2026-08-12 | +2.1% | -0.6% | GDRX higher |
| Gross margin as of 2026-08-12 | +90.8% | +72.9% | GDRX higher |
| Operating margin as of 2026-08-12 | +9.5% | -1.3% | GDRX higher |
| ROE as of 2026-08-12 | +2.6% | -2.5% | GDRX higher |
| ROA as of 2026-08-12 | +0.9% | -0.6% | GDRX higher |
| Debt / equity as of 2026-08-12 | 0.75 | 2.18 | GDRX lower |
| Revenue growth (YoY) as of 2026-08-12 | -1.8% | +32.8% | HIMS higher |
| Revenue CAGR (3y) SEC XBRL | +1.3% | +64.5% | HIMS higher |
| Beta as of 2026-08-12 | 1.72 | 2.46 | |
| 1-year return as of 2026-08-11 close | +9.2% | -39.0% | GDRX higher |
Fundamentals: market data, as of 2026-08-12. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-11.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.